SCHEMBL8780705

SCHEMBL8780705

c1cc(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c2cc3c(ccc4ccccc43)cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP1A2 P05177 2/20 0.44
HPGD P15428 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
HIF1A Q16665 2/20 0.42
CYP1B1 Q16678 1/20 0.42
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
TSHR P16473 2/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8780527 0.96 ALDH1A1 (0.47) ALDH1A1HSD17B10CYP1A2HPGDL3MBTL1
SCHEMBL18394742 0.94 L3MBTL1 (0.48) ALDH1A1HSD17B10CYP1A2HPGDL3MBTL1
SCHEMBL30005762 0.94 L3MBTL1 (0.48) ALDH1A1HSD17B10CYP1A2HPGDL3MBTL1
SCHEMBL8780702 0.90 KDM4E (0.44) ALDH1A1HSD17B10CYP1A2HPGDL3MBTL1
SCHEMBL9890871 0.90 L3MBTL1 (0.47) ALDH1A1HSD17B10HPGDL3MBTL1KDM4E
SCHEMBL18395044 0.90 L3MBTL1 (0.50) ALDH1A1HSD17B10HPGDL3MBTL1KDM4E
SCHEMBL30005900 0.90 L3MBTL1 (0.50) ALDH1A1HSD17B10HPGDL3MBTL1KDM4E
SCHEMBL8780718 0.89 L3MBTL1 (0.46) ALDH1A1HSD17B10CYP1A2HPGDL3MBTL1
SCHEMBL18548892 0.88 L3MBTL1 (0.46) ALDH1A1HSD17B10HPGDL3MBTL1KDM4E
SCHEMBL18406155 0.88 L3MBTL1 (0.48) ALDH1A1HSD17B10HPGDL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9499459-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-22 US disclosed
US-9499459-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2016-11-22 US disclosed
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-24 US disclosed
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-24 US disclosed
WO-2011012212-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2011-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120126180-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MYB, L1CAM, SLC25A21 ALDH1A1 507/4885HSD17B10 1679/4885CYP1A2 820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.